394 related articles for article (PubMed ID: 30370251)
41. Hematopoiesis and microenvironment in hematological malignancies.
Cheng H; Sun G; Cheng T
Cell Regen; 2018 Sep; 7(1):22-26. PubMed ID: 30671226
[TBL] [Abstract][Full Text] [Related]
42. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
43. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
[TBL] [Abstract][Full Text] [Related]
44. Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.
Yehudai-Resheff S; Attias-Turgeman S; Sabbah R; Gabay T; Musallam R; Fridman-Dror A; Zuckerman T
Int J Cancer; 2019 May; 144(9):2279-2289. PubMed ID: 30548585
[TBL] [Abstract][Full Text] [Related]
45. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
46. Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
Ciciarello M; Corradi G; Forte D; Cavo M; Curti A
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771483
[TBL] [Abstract][Full Text] [Related]
47. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
48. Imaging the Vascular Bone Marrow Niche During Inflammatory Stress.
Vandoorne K; Rohde D; Kim HY; Courties G; Wojtkiewicz G; Honold L; Hoyer FF; Frodermann V; Nayar R; Herisson F; Jung Y; Désogère PA; Vinegoni C; Caravan P; Weissleder R; Sosnovik DE; Lin CP; Swirski FK; Nahrendorf M
Circ Res; 2018 Aug; 123(4):415-427. PubMed ID: 29980569
[TBL] [Abstract][Full Text] [Related]
49. Targeting the microenvironment in acute myeloid leukemia.
Rashidi A; Uy GL
Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
[TBL] [Abstract][Full Text] [Related]
50. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
52. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
[TBL] [Abstract][Full Text] [Related]
53. [Chronic myeloid leukemia stem cells: cross-talk with the niche].
Chomel JC; Aggoune D; Sorel N; Turhan AG
Med Sci (Paris); 2014 Apr; 30(4):452-61. PubMed ID: 24801043
[TBL] [Abstract][Full Text] [Related]
54. Osteolineage cells and regulation of the hematopoietic stem cell.
Calvi LM
Best Pract Res Clin Haematol; 2013 Sep; 26(3):249-52. PubMed ID: 24309526
[TBL] [Abstract][Full Text] [Related]
55. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
56. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J; Chng WJ
Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
[TBL] [Abstract][Full Text] [Related]
57. Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment.
Bernasconi P; Borsani O
J Oncol; 2019; 2019():8323592. PubMed ID: 31485227
[TBL] [Abstract][Full Text] [Related]
58. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
59. The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation.
Reikvam H; Hatfield KJ; Fredly H; Nepstad I; Mosevoll KA; Bruserud Ø
Eur Cytokine Netw; 2012; 23(4):140-53. PubMed ID: 23328436
[TBL] [Abstract][Full Text] [Related]
60. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
